From HCLTech reporting its Q1FY27 results to Emcure Pharmaceuticals acquiring the remaining 12.05% stake in its subsidiary Gennova Biopharmaceuticals Ltd; here are stocks to track ahead of Tuesday trading session.
From HCLTech reporting its Q1FY27 results to Emcure Pharmaceuticals acquiring the remaining 12.05% stake in its subsidiary Gennova Biopharmaceuticals Ltd; here are stocks to track ahead of Tuesday trading session.